US20150119403A1 - Mutant ROS Expression In Human Cancer ...,https://www.google.com/patents/US20150119403?cl=ar
EP1848820A2 - Vagal afferent neurons as targets for treatment ...,https://www.google.com/patents/EP1848820A2
US20130210636A1 - Method and Kit for Performing Profiling of ...,http://www.google.com/patents/US20130210636
US20110190156A1 - Molecular signatures for diagnosing ...,http://www.google.com/patents/US20110190156
EP3146076A2 - Gene expression profiles associated with sub ...,https://www.google.com/patents/EP3146076A2
US20090048194A1 - Vagal Afferent Neurons as Targets for ...,https://www.google.com/patents/US20090048194
US20120244543A1 - Methods for in vitro differentiation of th-17+ ...,https://www.google.com/patents/US20120244543
EP1511466B1 - Use of glycosaminoglycans such as e.g. heparin for ...,https://www.google.com/patents/EP1511466B1?cl=nl
US20130331342A1 - Systems and methods for identifying cosmetic ...,http://www.google.com/patents/US20130331342
US20150246960A1 - Methods Of Producing A Secreted Protein ...,https://www.google.com/patents/US20150246960
